Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
about
Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management.Aldioxa improves delayed gastric emptying and impaired gastric compliance, pathophysiologic mechanisms of functional dyspepsia.Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaDyspepsia management in a resource poor setting.Relaxant effect of ethanol extract of Carum carvi on dispersed intestinal smooth muscle cells of the guinea pig.Gastric emptying scintigraphy in postprandial distress syndrome.
P2860
Q34589637-8D69908F-86C7-444B-BADE-22AD40D194CDQ34592603-1DDAA5C6-99FF-4C73-94F9-DBC1AC25A762Q36333444-25B36F43-8C55-493F-977B-E523B3A2172EQ38160491-F6A0E62C-8ABD-4938-9375-9D952B44ADE8Q42017984-54D4DE21-C158-46DF-BC71-15448AA255DBQ42964554-0BAEAEFB-A1A7-4BCA-B446-CCD947281B93Q55314091-AA81454E-E02D-458B-AFAC-291602E8C1E3
P2860
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@ast
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@en
type
label
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@ast
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@en
prefLabel
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@ast
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options.
@en
P2860
P1476
Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options
@en
P2093
Kieran J Moriarty
Richard Liston
P2860
P304
P356
10.1111/J.1572-0241.2004.04086.X
P407
P577
2004-04-01T00:00:00Z